Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:24 PM
Ignite Modification Date: 2025-12-25 @ 1:42 PM
NCT ID: NCT01472692
Description: The Principal Investigator for this study has passed away and the results data is not available.
Frequency Threshold: 0
Time Frame: None
Study: NCT01472692
Study Brief: Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Febuxostat Febuxostat: 80mg PO daily for 8 weeks 0 None 0 0 0 0 View
Placebo Febuxostat: 80mg PO daily for 8 weeks 0 None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):